The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Aug. 23, 2017
Applicants:

Glaxosmithkline Biologicals SA, Rixensart, BE;

University of Copenhagen, Copenhagen, DK;

Inventors:

Maria Rosaria Bassi, Copenhagen, DK;

Riccardo Cortese, Rome, IT;

Anna Morena D'Alise, Rome, IT;

Antonella Folgori, Rome, IT;

Peter Johannes Holst, Copenhagen, DK;

Alfredo Nicosia, Rome, IT;

Assignees:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 14/74 (2006.01); A61P 31/20 (2006.01); A61P 35/00 (2006.01); A61K 39/00 (2006.01); A61K 39/29 (2006.01); C07K 14/005 (2006.01);
U.S. Cl.
CPC ...
C07K 14/70539 (2013.01); A61K 39/0011 (2013.01); A61K 39/00119 (2018.08); A61K 39/29 (2013.01); A61P 31/20 (2018.01); A61P 35/00 (2018.01); C07K 14/005 (2013.01); A61K 2039/5256 (2013.01); A61K 2039/605 (2013.01); C07K 2319/00 (2013.01); C12N 2730/10122 (2013.01); C12N 2730/10134 (2013.01); C12N 2730/10171 (2013.01); C12N 2750/14143 (2013.01); C12N 2750/14171 (2013.01);
Abstract

The present application provides inter alia a fusion protein comprising a polypeptide wherein the polypeptide consists of a fragment of invariant chain which is operably linked to an antigenic sequence and wherein the fragment of invariant chain consists of a portion of residues 17-97 of SEQ ID NO: 1, wherein the portion comprises at least 5 contiguous residues from residues 77-92 of SEQ ID NO: 1.


Find Patent Forward Citations

Loading…